Ethyl but-3-enoate (contains <30ppm MEHQ as inhibitor), 88.0%, 5g

5,10-Dimethyl-5,10-dihydrophenazine, 95.0%, 10g

N-methyl-1-(5-methyl-1,3,4-oxadiazol-2-yl)methanamine, 95.0%, 1g

(S)-1-Benzyl 2-methyl pyrrolidine-1,2-dicarboxylate, 95.0%, 10g

4-Bromo-2-methylpyrimidine, 95.0%, 1g

(5-Bromo-2-ethoxypyridin-4-yl)boronic acid, 95.0%, 1g

8-OXABICYCLO[3.2.1]OCTAN-3-ONE, 95.0%, 10g

meso-3,4-Dibromo-2,2,5,5-tetrafluorotetrahydrofuran, 1g

n-(3-Aminopropyl)-N-methylmethanesulfonamide, 95%, 250mg

6-Chloroquinoline, 98.0%, 5g

Sodium 4-Hydroxy-3-methoxybenzoate>98.0%(GC)(T)5g

(E)-2,2-Diphenyl-5-(4-((pyridin-3-ylmethylene)amino)piperazin-1-yl)pentanenitrile, 99%, 5mg

Nicotinamide, 99.00%, 500g